Increased colonic expression of ACE2 associates with poor prognosis in Crohn's disease.
Increased colonic expression of ACE2 associates with poor prognosis in Crohn's disease.
复制标题
DOI:
10.1038/s41598-021-92979-2
复制
发表时间:
2021-06-29
影响因子:
4.6
通讯作者:
Sheikh SZ
中科院分区:
文献类型:
--
作者:
Toyonaga T;Araba KC;Kennedy MM;Keith BP;Wolber EA;Beasley C;Steinbach EC;Schaner MR;Jain A;Long MD;Barnes EL;Herfarth HH;Isaacs KL;Hansen JJ;Kapadia MR;Guillem JG;Gulati AS;Sethupathy P;Furey TS;Ehre C;Sheikh SZ
The host receptor for SARS-CoV-2, angiotensin-converting enzyme 2 (ACE2), is highly expressed in small intestine. Our aim was to study colonic ACE2 expression in Crohn's disease (CD) and non-inflammatory bowel disease (non-IBD) controls. We hypothesized that the colonic expression levels of ACE2 impacts CD course. We examined the expression of colonic ACE2 in 67 adult CD and 14 NIBD control patients using RNA-seq and quantitative (q) RT-PCR. We validated ACE2 protein expression and localization in formalin-fixed, paraffin-embedded matched colon and ileal tissues using immunohistochemistry. The impact of increased ACE2 expression in CD for the risk of surgery was evaluated by a multivariate regression analysis and a Kaplan–Meier estimator. To provide critical support for the generality of our findings, we analyzed previously published RNA-seq data from two large independent cohorts of CD patients. Colonic ACE2 expression was significantly higher in a subset of adult CD patients which was defined as the ACE2-high CD subset. IHC in a sampling of ACE2-high CD patients confirmed high ACE2 protein expression in the colon and ileum compared to ACE2-low CD and NIBD patients. Notably, we found that ACE2-high CD patients are significantly more likely to undergo surgery within 5 years of CD diagnosis, and a Cox regression analysis found that high ACE2 levels is an independent risk factor for surgery (OR 2.17; 95% CI, 1.10–4.26; p = 0.025). Increased intestinal expression of ACE2 is associated with deteriorated clinical outcomes in CD patients. These data point to the need for molecular stratification that can impact CD disease-related outcomes.
登录
查看更多内容
DOI:
10.1093/ecco-jcc/jjaa185
发表时间:
2021-03-05
期刊:
Journal of Crohn's & colitis
影响因子:
--
作者:
Verstockt B;Verstockt S;Abdu Rahiman S;Ke BJ;Arnauts K;Cleynen I;Sabino J;Ferrante M;Matteoli G;Vermeire S
通讯作者:
Vermeire S
影响因子:
5.9
作者:
Levy, David E.;Marie, Isabelle J.;Durbin, Joan E.
通讯作者:
Durbin, Joan E.
影响因子:
29.4
作者:
通讯作者:
--
影响因子:
8
作者:
Keith, Benjamin P.;Barrow, Jasmine B.;Sheikh, Shehzad Z.
通讯作者:
Sheikh, Shehzad Z.
影响因子:
4.9
作者:
Tinsley, Andrew;Navabi, Seyedehsan;Clarke, Kofi
通讯作者:
Clarke, Kofi